cd19 targeted car t-cell therapy in lbcl
Published 2 years ago • 198 plays • Length 45:46Download video MP4
Download video MP3
Similar videos
-
8:33
cd19-targeted car t-cell therapy in managing dlbcl
-
5:55
car t-cell therapy in dlbcl
-
2:53
advancements and challenges in car-t cell therapy
-
1:26:39
novel treatments for lymphoma: focus on targeted therapies
-
5:12
car t: cd19-targeted therapy in r/r dlbcl
-
11:18
car-t cells: engineered cancer killers
-
21:24
cell surface markers: cd3, cd4, cd8, cd19, cd28, cd16, cd56
-
1:06:53
new treatment horizon : chimeric antigen receptor car t cell therapy
-
2:23
outcomes in progressive large b-cell lymphomas following cd19-specific car t cells
-
2:36
cd19- and cd22-directed chimeric antigen receptor t-cell therapy in childhood b-cell all
-
2:37
efficacy of bispecific cd19/cd22 car t-cells in b-cell malignancies
-
2:19
investigating the genomic drivers of resistance to cd19 car-t therapy in dlbcl
-
1:51
current research on cd19 targeted car t-cells in relapsed b-cell all
-
55:58
role of cd19 car t cells in second line large b cell lymphoma
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
2:34
car t-cell therapy in dlbcl: centers of excellence
-
3:41
first multicenter trial of car t cells shows response in dlbcl
-
4:05
risk factors to predict post-cd19 car-t cell therapy outcomes in patients with lbcl
-
3:42
factors associated with treatment response to cd19 car t-cell therapy in b-all
-
3:23
second cd19-targeted car t-cell infusion for r/r b-cell malignancies
-
1:01
findings for cd19-targeted car t cells in combination with ibrutinib in cll
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells